Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMPVW2Q)

Drug Name
PMID30280939-Compound-US20179642901 Drug Info
Indication
Disease Entry ICD 11 Status REF
Malaria 1F40-1F45 Patented [1]
Cross-matching ID
TTD Drug ID
DMPVW2Q

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Toll-like receptor (TLR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
DPV-001 DMMC3XR Non-small-cell lung cancer 2C25.Y Phase 2 [2]
BDB001 DMKFJXP Solid tumour/cancer 2A00-2F9Z Phase 2 [3]
IMO-8400 DMDPNCJ Rheumatoid arthritis FA20 Phase 2 [4]
IMO-9200 DMEHWPC Autoimmune disease 4A40-4A45 Phase 1 [5]
PMID30280939-Compound-WO2009082440 DMXRHCJ N. A. N. A. Patented [1]
PMID30280939-Compound-WO2015150568 DMGCE3Z N. A. N. A. Patented [1]
PMID30280939-Compound-WO200606195 DMLVSEK N. A. N. A. Patented [1]
PMID30280939-Compound-WO2005070959 DM6VP5K N. A. N. A. Patented [1]
PMID30280939-Compound-WO2013148426 DMUKIEJ Malaria 1F40-1F45 Patented [1]
PMID30280939-Compound-WO2013148427 DM4Z2KY N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Toll-like receptor (TLR) TTOK0LR NOUNIPROTAC Agonist [1]

References

1 Synthetic Toll-like receptor agonists for the development of powerful malaria vaccines: a patent review.Expert Opin Ther Pat. 2018 Nov;28(11):837-847.
2 UbiVac's DRibble, autophagosome-enriched vaccines: Applications for cancer and infectious disease. UbiVac. 2013.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)